Professional
Added to YB: 2024-08-27
Pitch date: 2024-06-30
DGX [bullish]
Quest Diagnostics Incorporated
+50.27%
current return
Author Info
No bio for this author
Company Info
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
Market Cap
$21.7B
Pitch Price
$132.40
Price Target
N/A
Dividend
1.74%
EV/EBITDA
10.42
P/E
22.59
EV/Sales
2.54
Sector
Health Care Providers and Services
Category
value
FMI Funds Portfolio Holding: Quest Diagnostics Incorporated
DGX: Top US clinical lab co (24% mkt share). $85B industry, 2% of healthcare spend, influences 70% of medical decisions. Mid-single digit revenue growth, high-single digit earnings growth expected. 2-5x cheaper than hospital labs. Aging population & chronic disease drive growth. Low-double digit annual return potential at below-market valuation.
Read full article (1 min)